A groundbreaking preclinical study led by researchers at The Jackson Laboratory (JAX; ME, USA) has successfully utilized precision gene editing…
Read More
Precision DNA editing targets root cause of severe childhood epilepsy in a preclinical study.
In a landmark preclinical study, researchers from The Jackson Laboratory (JAX; Bar Harbor, ME, USA), in collaboration with the Broad…
Read More
UCB Acquires Neurona Therapeutics for Up to $1.15 Billion to Bolster Epilepsy Pipeline with Regenerative Cell Therapy
BRUSSELS, BELGIUM & SAN FRANCISCO, USA – April 20, 2026 – Global biopharmaceutical leader UCB has finalized a definitive agreement…
Read More
New drug cuts seizures by up to 91% in children with rare epilepsy
In a landmark development for pediatric neurology, an international clinical trial has demonstrated that an experimental genetic therapy, zorevunersen, can…
Read More
